3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
2
Sarcoma
1
Other hematologic neoplasm
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Conditions
Ovarian Neoplasms
535
Uterine Cervical Neoplasms
249
Fallopian Tube Neoplasms
239
Endometrial Neoplasms
142
Carcinoma, Ovarian Epithelial
135
Breast Neoplasms
101
Neoplasms
74
Carcinoma, Non-Small-Cell Lung
70
Colorectal Neoplasms
53
Uterine Cervical Dysplasia
49
Papillomavirus Infections
49
Neoplasm Metastasis
48
Pancreatic Neoplasms
46
Melanoma
44
Uterine Neoplasms
43
Prostatic Neoplasms
41
Urinary Bladder Neoplasms
40
Lung Neoplasms
40
Stomach Neoplasms
38
Peritoneal Neoplasms
37
Recurrence
36
Carcinoma, Renal Cell
35
Triple Negative Breast Neoplasms
33
Head and Neck Neoplasms
32
Esophageal Neoplasms
31
Small Cell Lung Carcinoma
30
Sarcoma
28
Vulvar Neoplasms
26
Vaginal Neoplasms
24
Testicular Neoplasms
22
Interventions
3-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Hypoxia
×
Gynecologic
×
Clear all
NCT01075399
2013-08-30
HX4-200
Siemens Molecular Imaging
Phase 2
Completed
50 enrolled
7 charts